Off-Label Prescriptions in Dermatology: Challenges of New Routes of Administration for Certain Old Drugs

被引:1
|
作者
Tasic-Kostov, Marija [1 ]
Ilic, Dusan [1 ]
机构
[1] Univ Nis, Fac Med, Dept Pharm, Nish, Serbia
关键词
off-label drug; dermatology; compounded drugs; drug vehicle; INFANTILE HEMANGIOMAS; TOPICAL PROPRANOLOL; SPIRONOLACTONE; THERAPY; SAFETY; ACNE; GEL;
D O I
10.5937/afmnai37-25282
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
"Off-label drug use" refers to the prescription of medications, with reference to indications, dosage, dosage form, patient group or route of administration, which are officially unapproved. Recently, new indications for some drugs have emerged and few of them are being used off-label to treat topically a variety of dermatological conditions. Off-label use is more common in dermatology than in other medical specialties, and those drugs are basically available as compounded formulations, but the choice of a proper vehicle and safety of extemporaneous drug preparation intended for topical use are usually neglected in case of systemic drugs. Moreover, the bases commonly used as vehicles for extemporaneous dermatological preparations are stabilized with traditional surfactants known for their potential to irritate skin, while inflammatory dermatoses can worsen when exposed to irritants In this paper, we have listed several systemic drugs which are being used in topical treatment of some frequent dermatological conditions, but not according to their officially approved indications. The choice of drugs was made according to the topical off-label dermatological prescriptions obtained from public pharmacies. The aim was also to review data related to, in our opinion, two major drawbacks of using off-label topical drugs: safety data on the use of the final dermal preparation and scientific information relevant for the choice of a proper topical vehicle for specific drug and proper stability evaluation.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 43 条
  • [31] Evaluation of Clinical Compendia Used for Medicare Part D Coverage Determinations for Off-label Prescribing in Dermatology
    Barbieri, John S.
    St Claire, Kayla
    Mostaghimi, Arash
    Albrecht, Joerg
    JAMA DERMATOLOGY, 2019, 155 (03) : 315 - 320
  • [32] Advancing perspectives on the off-label use of anticancer drugs: an updated classification and exploration of categories
    Chen, Xiaoyi
    Ou, Shunlong
    Luo, Jing
    He, Zhisan
    Jiang, Qian
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [33] Off-label drugs in otolaryngological practice against the background of legal conditions of Polish legislation
    Kopczyk, Renata
    Jurkiewicz, Dariusz
    Rogowski, Marek
    Szydlowski, Maciej
    Wierzbicka, Malgorzata
    POLISH JOURNAL OF OTOLARYNGOLOGY, 2024, 78 (01): : 36 - 43
  • [34] Off-Label Use of Drugs and Devices: Role of Medical Professionals in the Establishment of Parameters for Their Use
    Long, Donlin
    Watts, Clark
    NEUROSURGERY, 2013, 72 (06) : 1014 - 1020
  • [35] Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system
    Wong, Jenna
    Motulsky, Aude
    Abrahamowicz, Michal
    Eguale, Tewodros
    Buckeridge, David L.
    Tamblyn, Robyn
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 356
  • [36] Use of off-label nephrology-related drugs in hospitalized pediatric patients: a retrospective study
    Marchella Yasinta
    Ruo-Chen Che
    Cai-Yu Hu
    Xiang-Hui Du
    Gui-Xia Ding
    Song-Ming Huang
    Ying Chen
    Ai-Hua Zhang
    World Journal of Pediatrics, 2016, 12 : 236 - 242
  • [37] A capture-recapture method or estimating the incidence of off-label prescriptions: the example of baclofen or alcohol use disorder in France
    Auffret, Marine
    Rolland, Benjamin
    Behal, Helene
    Labreuche, Julien
    Jouanjus, Emilie
    Bordet, Regis
    Gautier, Sophie
    THERAPIE, 2019, 74 (06): : 645 - 650
  • [38] Off-label and unlicensed drug use in neonatal intensive care units in Turkey: the old-inn study
    S. Suna Oguz
    H. Gozde Kanmaz
    Ugur Dilmen
    International Journal of Clinical Pharmacy, 2012, 34 : 136 - 141
  • [39] Off-label and unlicensed drug use in neonatal intensive care units in Turkey: the old-inn study
    Oguz, S. Suna
    Kanmaz, H. Gozde
    Dilmen, Ugur
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (01) : 136 - 141
  • [40] Off-label use of psychotropic drugs in a Swiss paediatric service: similar results from two different cohort studies
    Feka, Alma
    Di Paolo, Ermindo R.
    Pauchard, Jean-Yves
    Mariguesa, Alexandra
    Gehri, Mario
    Sadeghipour, Farshid
    SWISS MEDICAL WEEKLY, 2022, 152